Abstract
We have recently demonstrated the potential of 18F-FDG as an imaging marker of myocardial ischemia if injected at peak exercise. However, how long increased 18F-FDG uptake can be observed after an episode of exercise-induced myocardial ischemia is not known. We performed the current study to determine whether increased regional myocardial 18F-FDG uptake at exercise in patients with coronary artery disease (CAD) persists on rest imaging (24 h later), after an episode of exercise-induced myocardial ischemia. Methods: Twenty-four patients with suspected CAD underwent exercise 99mTc-sestamibi and 18F-FDG imaging. Repeated 18F-FDG imaging was performed 24 h after exercise imaging, after an injection of a second dose of 18F-FDG at rest in 20 patients. Perfusion imaging with 99mTc-sestamibi was simultaneously performed with 18F-FDG imaging. All patients underwent coronary angiography. Results: Eighteen patients had greater than or equal to 70% luminal narrowing of 1 or more coronary vessels. Fifteen patients (83%) showed increased regional 18F-FDG uptake on exercise imaging, but only 11 patients (61%) had perfusion abnormalities. Of these 15 patients with increased regional 18F-FDG uptake on exercise imaging, 8 (53%) had no discernible 18F-FDG uptake, 5 (33%) had decreased 18F-FDG uptake, and only 2 (13%) had persistent 18F-FDG uptake on rest 18F-FDG images. The summed 18F-FDG uptake score significantly decreased, from 14.4 ± 10.3 at exercise to 6.7 ± 9.2 at rest (P = 0.01). Patients with persistent 18F-FDG uptake at rest had more 18F-FDG uptake and lower peak rate–pressure product at exercise, compared with patients with no residual 18F-FDG uptake at rest. Conclusion: Exercise-induced regional myocardial 18F-FDG uptake is highly specific and sensitive for exercise-induced myocardial ischemia. Regional myocardial 18F-FDG uptake may persist 24 h after an episode of exercise-induced myocardial ischemia in some patients.
Scintigraphic myocardial perfusion imaging is a widely used noninvasive modality for the detection and risk stratification of coronary artery disease (CAD) (1). Despite its extensive use, this technique suffers from several limitations. Artifacts during image acquisition and reconstruction degrade the image quality. Rest–stress imaging sequences take several hours to complete. Despite a high sensitivity of exercise–rest perfusion imaging for the detection of CAD, its sensitivity for the detection of individual vessels with significant disease is not high (2). A technique for direct imaging of myocardial ischemia can potentially overcome some of these limitations. Myocardial ischemia results in a dramatic and sustained switch to glucose uptake (3–7). A differential uptake of glucose between normal and ischemic myocardium can be used for hot-spot imaging of myocardial ischemia. Several studies have recently documented the potential of 18F-FDG as an ischemic marker (8–12), and a successful demonstration of 18F-FDG as an ischemia imaging agent also raises several important questions (13). A series of carefully planned studies is needed to address these issues before stress 18F-FDG imaging can be considered for routine clinical use. An important issue is how long after an episode of exercise-induced myocardial ischemia increased myocardial 18F-FDG uptake can be observed. This information is critical for designing an optimal clinical imaging protocol for imaging exercise-induced myocardial ischemia with 18F-FDG and for understanding the pathophysiology and molecular biology of myocardial ischemia.
In experimental animal studies, upregulation of glucose uptake by the ischemic myocardium can persist for hours to days, even after a brief episode of ischemia (6,7). It is quite likely, but not necessarily definitive, that in humans increased regional 18F-FDG uptake may also persist for several hours after an episode of exercise-induced myocardial ischemia. Moreover, whether this persistence of increased regional 18F-FDG uptake would allow diagnostic-quality images to be obtained if 18F-FDG were injected hours after an episode of exercise-induced myocardial ischemia and whether the persistence of 18F-FDG uptake correlates with the severity of ischemia or with the severity of luminal obstruction of coronary arteries are both unclear. This information is important for the evaluation of 18F-FDG as a memory marker of myocardial ischemia.
In the present study, we repeated 18F-FDG imaging 24 h after exercise by injecting a second dose of 18F-FDG at rest in patients with CAD who showed increased 18F-FDG uptake at exercise. The primary aim of this study was to determine whether increased myocardial 18F-FDG uptake at exercise persists at rest after (24 h) an episode of exercise-induced myocardial ischemia. The secondary aims were to determine the frequency of the occurrence of persistent 18F-FDG uptake after an episode of exercise-induced myocardial ischemia and to determine its relationship with the clinical, angiographic, and scintigraphic variables.
MATERIALS AND METHODS
Patients
Patients with strong clinical suggestion of CAD, based on the symptoms of exertional angina and risk factors for CAD, or patients with angiographic CAD were enrolled. Patients were excluded if they had 1 of the following conditions: prior myocardial infarction (history of previous documented myocardial infarction or Q waves on electrocardiogram consistent with prior myocardial infarction), diabetes mellitus, unstable angina, prior coronary revascularization, or inability to exercise. Patients with diabetes were excluded because of the logistic difficulties in controlling variables such as the degree of control, pharmacotherapy, and fasting for at least 12 h for imaging sessions. Written informed consent was obtained from the patients before they enrolled, and the protocol was approved by the institutional review board.
Study Protocol
All patients underwent exercise myocardial 99mTc-sestamibi and 18F-FDG imaging. Patients with increased myocardial 18F-FDG uptake on exercise 18F-FDG images underwent a repeated 99mTc-sestamibi and 18F-FDG scan using a second injection of 99mTc-sestamibi and 18F-FDG 24 h later. The exercise testing and imaging protocol have been described previously (11). In brief, after overnight fasting (>12 h), a symptom-limited exercise test using a bicycle ergometer was performed with continuous electrocardiography and blood pressure monitoring. Antianginal medications (β-blockers, calcium channel blockers, and nitrates) were withheld for at least 12 h before exercise testing. 99mTc-sestamibi (740–925 MBq) and 18F-FDG (185–296 MBq) were injected intravenously at peak exercise. Simultaneous tomographic images of 99mTc-sestamibi and 18F-FDG were acquired 1–2.5 h (mean, 92 min; range, 60–136 min) after tracer injection. Rest imaging was performed on the next day (the interval between exercise and rest imaging was 23.5 h; range, 23.1–23.9 h). The patients also fasted overnight before rest imaging. Image acquisition was performed 1–2.5 h after tracer injection (mean, 127 min). Blood sugar levels were measured just before the exercise test and before injection of the tracers at rest imaging. Figure 1 describes the study protocol.
Image Acquisition and Reconstruction
Images were acquired using a dual-head, large-field-of-view SPECT camera (Varicam; GE Healthcare), equipped with a 1.6-cm (5/8-in)-thick crystal and ultra-high-energy parallel-hole collimators. Thirty projection images were acquired over a 180° arc at 6° intervals. The acquisition time was 50 s at each projection. Both exercise and rest myocardial images were reconstructed using standard filtered backprojection and displayed as a series of short-axis and horizontal and vertical long-axis slices. Two separate sets of tomographic slices for exercise 99mTc-sestamibi and 18F-FDG were simultaneously obtained, with exact correspondence in spatial orientation.
Image Interpretation
Perfusion and 18F-FDG ischemia images were visually interpreted by 2 experienced nuclear cardiologists, in a masked manner. The differences were resolved by consensus. Perfusion images on both exercise and rest 99mTc-sestamibi imaging were scored using a 17-segment model and 5-score scale (0, normal uptake; 1, mild reduction in uptake; 2, moderate reduction in uptake; 3, severe reduction in uptake; and 4, no uptake). Myocardial segments were scored as normal, ischemic, ischemic and scarred, or scarred on the basis of abnormalities on stress and rest images. 18F-FDG images were scored using the same 17-segment model on a 0–2 scale (0, no discernible 18F-FDG uptake above the background level; 1, mild uptake but above the background level; and 2, intense uptake). Myocardial segments with uptake scores of 1 and 2 were defined as showing ischemia. Stress and rest 18F-FDG images were compared for changes in 18F-FDG uptake observed on stress images. Changes were classified as no uptake on rest images with a change in scores to 0 from 1 or 2 on exercise images. Decreased 18F-FDG uptake was defined as a decrease in 18F-FDG uptake score from 2 to 1, and persistent 18F-FDG uptake was defined as no change or an increase from 1 to 2. The summed 18F-FDG uptake score was obtained by summing the score of each segment. Myocardial segments were assigned to vascular territories for angiographic comparison as follows: anterior and septal segments to the left anterior descending coronary artery, lateral segments to the left circumflex coronary artery, and inferior segments to the right coronary artery.
Coronary Angiography and Left Ventriculography
Coronary angiography was performed within 1 wk of scintigraphy and interpreted by 2 expert interventional cardiologists. The presence, localization, and severity of coronary arteries were analyzed using quantitative coronary angiographic analysis. Luminal diameter narrowing of 70% or more in any of the major epicardial coronary arteries was considered significant disease, luminal narrowing in the range of 50%−69% was considered mild disease, and luminal narrowing of less than 50% was considered insignificant disease. Left ventriculography was performed in the 30° right anterior oblique projection, left ventricular ejection fraction was calculated using the area–length method, and wall motion was visually assessed.
Statistical Analysis
Continuous variables are described as mean and SD of the means, and categoric variables are described as frequencies. The paired t test was used to compare the difference in continuous variables between exercise and rest values. To determine the variables related to persistent 18F-FDG uptake, the Mann–Whitney U test was used to compare the difference in continuous variables, and the χ2 test was used to compare the difference in categoric variables. A P value of less than 0.05 was considered significant.
RESULTS
Twenty-six patients were initially recruited. Two patients were excluded because one patient did not undergo angiography, and the other, who showed increased 18F-FDG uptake on exercise imaging, declined rest imaging. The remaining 24 patients (21 men; age, 60 ± 10 y) constitute our patient population.
Exercise Testing
The mean exercise time was 442 ± 135 s (range, 208–683 s). Heart rate increased from 64 ± 13 beats per minute at baseline to 119 ± 18 beats per minute at peak exercise (P < 0.0001); systolic blood pressure increased from 133 ± 24 mm Hg to 171 ± 23 mm Hg (P < 0.0001). During exercise testing, chest pain developed in 14 patients and ischemic electrocardiography changes in 13.
Coronary Angiography
Eighteen patients showed greater than or equal to 70% luminal narrowing of 1 or more coronary vessels or their major branches. Two patients showed only mild disease (50%−69% luminal narrowing range), and 4 had no luminal narrowing (Table 1). Left ventricular wall motion and ejection fraction were normal in all patients.
99mTc-Sestamibi Images
Eleven of 18 patients (61%) with significant CAD had perfusion abnormalities. Of these, 7 patients had reversible perfusion abnormalities, 4 had partially reversible perfusion abnormalities, and none had persistent defects. None of the 2 patients with mild CAD or the 4 patients with no CAD had perfusion abnormalities. Of 39 vascular territories supplied by arteries with luminal narrowing of at least 50%, 12 (31%) had perfusion abnormalities on exercise images; of 31 vascular territories with luminal narrowing of at least 70%, 12 (39%) had perfusion abnormalities.
Exercise 18F-FDG Imaging
Fifteen of 18 patients (83%) with significant CAD had increased myocardial 18F-FDG uptake. Of the 15, 3 had 1-vessel disease, 6 had 2-vessel disease, and 6 had 3-vessel disease. None of the 2 patients with mild CAD or 4 patients with no CAD had increased 18F-FDG uptake.
Of 39 vascular territories with luminal narrowing of 50% or more, 22 (56%) had increased 18F-FDG uptake; of 31 vascular territories with luminal narrowing of 70% or more, 19 (61%) had increased 18F-FDG uptake. Six vascular territories with no significant luminal obstruction had abnormal 18F-FDG uptake. However, this uptake was seen in myocardial segments adjoining the vascular territories with significant luminal obstruction and intense 18F-FDG uptake.
Change in Myocardial 18F-FDG Uptake from Exercise to Rest Imaging
Fifteen patients with increased 18F-FDG uptake on exercise imaging underwent rest imaging. Table 2 shows the change in myocardial 18F-FDG uptake from exercise to rest imaging. Eight of these 15 patients (53%) with increased 18F-FDG uptake on exercise imaging had no discernible 18F-FDG uptake, 5 patients (33%) had decreased 18F-FDG uptake, and only 2 patients (13%) had persistent 18F-FDG uptake at rest (Figs. 2–4⇓⇓). The summed 18F-FDG uptake score significantly decreased from 14.4 ± 10.3 (range, 2–34) at exercise to 6.7 ± 9.2 (range, 0–28) at rest (P < 0.01).
18F-FDG uptake was observed in 28 vascular territories on exercise images (22 with ≥50% narrowing of coronary arteries and 6 with normal coronaries). By vascular territory analysis, 12 (43%) of the 28 vascular territories with increased 18F-FDG uptake at exercise showed no 18F-FDG uptake, 12 (43%) showed decreased 18F-FDG uptake, and 4 (14%) showed persistent 18F-FDG uptake at rest. The average 18F-FDG uptake score of those vascular territories decreased from 7.7 ± 3.5 at exercise to 3.1 ± 4.1 at rest (P < 0.0001).
By segmental analysis, 123 segments showed 18F-FDG uptake at exercise. Of these, 73 (59%) showed no 18F-FDG uptake, 16 (13%) showed decreased uptake at rest, and only 34 (28%) showed persistent 18F-FDG uptake. The average 18F-FDG uptake score of those segments decreased from 1.7 ± 0.4 at exercise to 0.7 ± 0.9 at rest (P < 0.0001).
Five of 9 patients who had no 18F-FDG uptake on exercise imaging underwent rest imaging (3 had angiographic CAD and 2 had normal coronary arteries). None of these patients showed any 18F-FDG uptake on rest images.
Variables Related to Persistent 18F-FDG Uptake
Those patients with residual (persistent or decreased) 18F-FDG uptake had more 18F-FDG uptake and a lower rate–pressure product at peak exercise than did patients with no residual 18F-FDG uptake at rest (Table 3). The vascular territories with residual 18F-FDG uptake had more 18F-FDG uptake at exercise than did vascular territories with no residual 18F-FDG uptake (Table 4).
DISCUSSION
These data show that a majority (87%) of patients with exercise-induced myocardial 18F-FDG uptake had no discernible uptake or decreased 18F-FDG uptake at 24 h after exercise. This finding indicates that in this patient population, exercise-induced increased regional myocardial 18F-FDG uptake is specific for exercise-induced myocardial ischemia. Nevertheless, ischemic 18F-FDG uptake may persist 24 h after exercise in some patients.
Duration of 18F-FDG Uptake After Myocardial Ischemia
It is well known that myocardial ischemia is accompanied by increased exogenous glucose use in experimental animal models (3–7). 18F-FDG, an analog of glucose, is a suitable agent for imaging myocardial ischemia (13–15).
In experimental animal studies, a postischemic increase of myocardial glucose uptake can persist for 24 h or longer. McNulty et al. (6) demonstrated that reperfused myocardial regions exhibited an increase in absolute 18F-FDG activity relative to the control region, ranging from 40% in the endocardium to 15% in the epicardium. In the present study, the exercise-induced myocardial 18F-FDG uptake substantially decreased but may persist in some patients when 18F-FDG was reinjected 24 h later.
Exercise 18F-FDG for Myocardial Ischemia Imaging
Human studies from our group and others have investigated the feasibility of imaging ischemia with 18F-FDG in different patient subgroups and using different study protocols (8–12). In the present series of 18 patients with significant coronary stenosis, 83% showed regional 18F-FDG uptake on exercise imaging, but only 61% had perfusion abnormalities. The results of this study confirm our previous results (11) and indicate the potential superiority of exercise 18F-FDG and perfusion imaging over exercise and rest perfusion imaging for the detection of CAD. Simultaneous exercise 18F-FDG and perfusion imaging has higher sensitivity than does exercise–rest perfusion imaging and detects more vascular territories with significant luminal narrowing.
Interplay Between Fatty Acid and Glucose Metabolism During Myocardial Ischemia
The present study demonstrates that exercise-induced myocardial 18F-FDG uptake may persist 24 h after exercise. Our findings are supported by prior data in experimental animals, in which upregulation of glucose uptake by the ischemic myocardium was shown to persist for hours to days, even after a brief episode of ischemia (6,7). Furthermore, Dilsizian et al. (16) recently demonstrated that prolonged suppression of fatty acid correlates with the magnitude of exercise-induced perfusion abnormality, and β-methyl-p-123I-iodophenyl-pentadecanoic acid imaging can demonstrate the metabolic imprint of an exercise-induced ischemic episode within 30 h. The metabolic changes after myocardial ischemia might be imaged with SPECT and PET. It will be of great significance to correlate the glucose and fatty acid imaging on the postischemic imaging.
Study Limitations
Left ventricular wall motion was not simultaneously evaluated during the imaging period because of a technical reason: the relationship between persistence of 18F-FDG uptake and the abnormalities of left ventricular wall motion cannot be determined. Second, although the 18F-FDG uptake was visually scored in the present study, 18F-FDG uptake on both exercise and rest images might be more reliably scored using some quantitative method. However, no such quantitative program is currently available. Finally, myocardial uptake of glucose may be influenced by substrate availability: insulin, free fatty acids, and catecholamine levels at the time of 18F-FDG injection were not determined in this study. Further study of a larger sample size should be performed with quantitative analysis, and the repeatability of exercise-induced myocardial 18F-FDG uptake and the effect of substrate need to be evaluated.
CONCLUSION
Exercise-induced regional myocardial 18F-FDG uptake is highly specific and sensitive for exercise-induced myocardial ischemia. Regional myocardial 18F-FDG uptake may persist 24 h after an episode of exercise-induced myocardial ischemia.
Acknowledgments
This study was supported by Specialized Research Fund for the Doctoral Program of Higher Education (20040023009) from the Ministry of Education, China.
Footnotes
-
↵* Contributed equally to this work.
-
COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.
References
- Received for publication March 31, 2008.
- Accepted for publication May 28, 2008.